Letrozole before surgery for early-stage breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests whether taking letrozole, a hormone-blocking pill, before surgery can help shrink estrogen-positive breast cancer. It is for women who have gone through menopause and have early-stage cancer that has spread to nearby lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 69 years old.
- You have gone through menopause (confirmed by a blood test).
- You have a type of breast cancer called infiltrating ductal carcinoma.
- Your tumor is small (up to 5 cm) and has spread to nearby lymph nodes but not further.
- Your cancer is estrogen-receptor positive and HER2-negative.
- You have not had prior hormone therapy or chemotherapy for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (SHR-A1811) alone or with letrozole given before surgery to shrink early-stage breast cancer that is hormone receptor-positive and HER2-low. It may help make surgery more effective.
This trial tests whether taking hormone therapy before surgery can improve outcomes for women with a specific type of breast cancer called lobular breast cancer. If you qualify, you would receive endocrine therapy for 6 months before your planned breast-conserving surgery.
This trial is testing how well a short course of hormone-blocking pills (endocrine therapy) works before surgery in women with early-stage hormone receptor-positive HER2-negative breast cancer. The goal is to understand what makes some cancers resistant to these treatments.
This trial tests giving chemotherapy before surgery to shrink breast tumors, which may make surgery easier or allow breast-conserving options. It is for adults with invasive breast cancer that has not spread to distant organs.
This trial tests if giving hormone-blocking pills before surgery can help guide which treatments you need after surgery. It is for premenopausal women with early-stage, hormone-sensitive breast cancer.
This trial tests if a lower dose of the hormone therapy drug letrozole can work as well as the standard dose for people with early-stage hormone receptor-positive breast cancer. The lower dose may cause fewer side effects while still helping to prevent the cancer from coming back.
Hear when a new Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.